Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Breaking the Medicare, OPPS logjam

The stalemate that prevented the Senate from passing Medicare reform legislation in 2000 and 2002 has been broken, making it very probable that a law will be enacted this year providing comprehensive prescription drug coverage to senior citizens.

The breakthrough also moves the Biotechnology Industry Organization a step closer to overturning Medicare pricing policies that the biotech sector has complained unfairly penalize innovator drugs and biologics.

Overall, both houses of Congress have settled on approaches that attempt to split the difference between President Bush's preference to completely overhaul Medicare so

Read the full 890 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE